During this year´s AACR Annual Meeting, Washington DC, April 6 -10, ecancer caught up with VHIO´s Laura Soucek, PI of the Mouse Models of Cancer Therapies Group, to discuss her group´s pioneering work on Myc inihibition in pre-clinical mouse models.
Related Posts
Source: the ”la Caixa” Banking Foundation Josep Baselga, María Blasco, Valentí Fuster, Maite Mendioroz, Eduard Gratacós, Bonaventura Clotet and Pedro…
VHIO Meet the Editors with The New England Journal of Medicine: Monday 14 May 2012
The New England Journal of Medicine´s Bette Phimister, Deputy Editor, will join us to deliver the next in the prestigious series of VHIO Meet the Editors talks:
Publishing Advances in Cancer Research
Bette Phimister will review progress and pitfalls in cancer research and issues concerning its publication, with a focus on targeted therapies and an eye to future developments.
EACR 22 – from Basic Research to Personalised Cancer Treatment, 7 – 10 July 2012, Barcelona, Spain, is pleased to announce the following Pre-Congress Sympoium:
The Seve Ballesteros Foundation Special Conference on Brain Cancer, Saturday 7 July, 08:30 – 12:30h.
CALL FOR APPLICATIONS 2012 The objective of the Fellowship is to provide support to two outstanding MD’s, PhD’s, or MD/PhD’s…
The European Research Council (ERC) has awarded Joan Seoane, Director of Translational Research at the Vall d’Hebron Institute of Oncology…
The Vall d’Hebron Institute of Oncology (VHIO) has published a new study describing a new molecular mechanism that regulates the renewal of the glioma stem cells. The findings represent an important advancement in the research centred on one of the most aggressive brain tumours, the glioblastoma multiforme
• Promising results from a Phase II study evidence the clinical gains of combinatorial therapy with BRAF inhibitors for patients…
• The phase II study, published in The New England Journal of Medicine, shows that the most common mutation of…
Important advances in next-generation whole-genome sequencing for precision oncology have led to the development of multiplex panel testing for the…
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
Reserve you place today to join Cancer Discovery´s Executive Editor, Judy Quong, for what promises to be a compelling talk…
Barcelona, 27 August, 2015.– Latest research published in Clinical Cancer Research by the Vall d´Hebron Institute of Oncology´s (VHIO) Stem…
Marking the second in the prestigious series of talks: VHIO Meet the Editors, Science´s Paula Kiberstis, Senior Editor, cancer research, will be joining us to deliver what promises to be a highly insightful presentation on Demystifying Science.
The European Society for Medical Onocology (ESMO) has just announced that the President for 2020-2021 is Solange Peters, MD, PhD,…
Taking place on Monday 24 February 2014, 09:15 – 10:30, at the Hotel Alimara Barcelona, we are delighted to announce…